Article Information
PubMed
Published By
History
- Received October 13, 2008
- Revision received February 12, 2009
- Accepted February 27, 2009
- First published April 15, 2009.
- Version of record published April 15, 2009.
Copyright & Usage
Copyright © 2009 Society for Neuroscience 0270-6474/09/294708-11$15.00/0
Author Information
- Susana Ferrao Santos1,
- Nathalie Pierrot1,
- Nicole Morel3,
- Philippe Gailly3,
- Christian Sindic2, and
- Jean-Noël Octave1
- 1Experimental Pharmacology Unit and
- 2Neurology Department, Institute of Neuroscience, and
- 3Laboratory of Cell Physiology, Université catholique de Louvain, B-1200 Brussels, Belgium
- Correspondence should be addressed to Jean-Noël Octave, Experimental Pharmacology Unit, Université catholique de Louvain, FARL/UCL 54 10, avenue Hippocrate 54, B-1200 Brussels, Belgium. jean-noel.octave{at}uclouvain.be
Author contributions
Disclosures
- Received October 13, 2008.
- Revision received February 12, 2009.
- Accepted February 27, 2009.
-
This work was supported by the Belgian Fonds National pour la Recherche Scientifique (FNRS-FRS), by Interuniversity Attraction Poles Programme–Belgian State–Belgian Science Policy, the Communauté Française de Belgique, Actions de Recherche Concertés, The Belgian Fonds de la Recherche Scientifique Médicale, the Fondation pour la Recherche sur la Maladie d'Alzheimer (FRMA), and the Programme d'excellence “Marshall” DIANE convention. We thank L. Mercken for the generous gift from DAPT, J.-P. Brion for providing the B9 anti-MAP2 antibody, and P. Kienlen-Campard and A. Goffinet for critical reading of this manuscript.
- Correspondence should be addressed to Jean-Noël Octave, Experimental Pharmacology Unit, Université catholique de Louvain, FARL/UCL 54 10, avenue Hippocrate 54, B-1200 Brussels, Belgium. jean-noel.octave{at}uclouvain.be
Online Impact